Clinical Research Directory

Inclusion Criteria: * Subjects must be diagnosed with Stage III or Stage IV ovarian carcinoma (which includes primary peritoneal carcinoma or fallopian rube carcinoma) * All subjects must be enrolled within 90 days of diagnosis * No prior treatment for ovarian carcinoma * All subjects have agreed to a treatment plan of neoadjuvant chemotherapy and subsequent planned interval debulking surgery with an MSKCC surgeon * Participants must be initiating treatment at Gynecologic Medical Oncology clinics at MSKCC Manhattan * Proficiency in English in the determination of the investigators of by patient self-report Exclusion Criteria: * Patient under age 18 * Prior treatment for ovarian cancer * Second opinion visit only * Immediate surgery plan without neoadjuvant treatment * No intended surgical plan * Chemotherapy administration exclusively planned at MSKCC regional site * Patient unwilling to sign consent